AT Akari Therapeutics Plc Stock: price and management transactions · United States · SEC (Form 4)Follow the Akari Therapeutics Plc stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €15.4m. The latest transaction was reported on 19 August 2026 (Attribution). Among the most active insiders: Patel Samir Rashmikant. The full history is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Akari Therapeutics Plc Strong Buy (bullish), based on 2 analysts. Average price target: US$28.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
All Executives49 Thresholds0 Prospectus0 Other0
Declarations 49 total
◆ Interim CFO · Executives · 17 Aug 2026
1,728 shares @ US$7.52 American Depositary Shares representing Ordinary Shares SEC:0001493152-26-039246:0
◆ Interim CFO · Executives · 16 Jul 2026
1,130 shares @ US$11.50 0.095% mcap 21.2% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-26-036231:0
◇ Director · Executives · 7 Jul 2026
1,209 shares @ US$8.00 0.046% mcap 0.4% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-26-033634:0
◇ Director · Executives · 7 Jul 2026
15,466 shares @ US$0.0004 0.0000% mcap 0.0% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-26-033634:1
◇ Director · Executives · 7 Jul 2026
5,799 shares @ US$0.0004 0.0000% mcap 0.0% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-26-033634:2
◆ Interim CFO · Executives · 24 Jun 2026
1,248 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:0
◆ Interim CFO · Executives · 24 Jun 2026
1,395 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:1
◆ Interim CFO · Executives · 24 Jun 2026
1,570 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:2
◆ Interim CFO · Executives · 24 Jun 2026
2,539 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:3
◆ Interim CFO · Executives · 24 Jun 2026
3,725 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:4
◆ Interim CFO · Executives · 24 Jun 2026
7,353 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:5
◆ Interim CFO · Executives · 24 Jun 2026
1,000 shares American Depositary Shares representing Ordinary Shares SEC:0001493152-26-030210:6
◆ Interim CFO · Executives · 1 Nov 2025
32,000 shares @ US$0.75 54.6% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-25-020753:0
◆ Interim CFO · Executives · 1 Nov 2025
26,619 shares @ US$0.75 45.4% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-25-020753:1
◆ Interim CFO · Executives · 22 Oct 2025
6,277 shares @ US$0.74 9.5% of flow American Depositary Shares representing Ordinary Shares SEC:0001493152-25-019194:0
▲ CEO · Executives · 21 Aug 2025
10,000 shares @ US$0.94 2.9% of flow American Depositary Shares representing Ordinary Shares SEC:0001641172-25-026025:0
Canonical exit: 19 Nov 2025 (T+90) ▲ President & CEO · Executives · 23 Jun 2025
943 shares @ US$1.15 0.3% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-089976:0
Canonical exit: 21 Sept 2025 (T+90) ▲ President & CEO · Executives · 20 Jun 2025
10,000 shares @ US$1.20 4.9% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-089462:0
Canonical exit: 18 Sept 2025 (T+90) ▲ President & CEO · Executives · 17 Jun 2025
15,000 shares @ US$1.20 5.8% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-088490:0
Canonical exit: 15 Sept 2025 (T+90) ◆ CEO · Executives · 12 Jun 2025
20,000 shares @ US$1.23 8.3% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-086829:0
◆ CEO · Executives · 10 Jun 2025
20,000 shares @ US$1.27 9.5% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-085472:0
◆ Director · Executives · 6 Mar 2025
44,642 shares @ US$1.12 100.0% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-060298:0
◆ Director · Executives · 6 Mar 2025
4,464 shares @ US$1.12 45.2% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-036485:0
◆ Director · Executives · 6 Mar 2025
406,250 shares @ US$1.12 21.0% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-036486:0
◆ Director · Executives · 6 Mar 2025
446,428 shares @ US$1.12 22.7% of flow American Depositary Shares representing Ordinary Shares SEC:0000950170-25-036487:0
25 of 49 declarations
Load more (24 remaining) 关于 Akari Therapeutics Plc Akari Therapeutics Plc 是一家生物制药公司，专注于开发自身免疫疾病和炎症性疾病的治疗方法。该公司在纳斯达克上市，股票代码为 AKTX。